• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1-溴-3-(1',1'-二甲基烷基)-1-去氧-Δ(8)-四氢大麻醇:大麻素 CB(2)受体的新型选择性配体。

1-Bromo-3-(1',1'-dimethylalkyl)-1-deoxy-Δ(8)-tetrahydrocannabinols: New selective ligands for the cannabinoid CB(2) receptor.

机构信息

Howard L. Hunter Laboratory, Clemson University, Clemson, SC 29634-0973, United States.

出版信息

Bioorg Med Chem. 2010 Nov 15;18(22):7809-15. doi: 10.1016/j.bmc.2010.09.061. Epub 2010 Sep 29.

DOI:10.1016/j.bmc.2010.09.061
PMID:20943404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2978510/
Abstract

Δ(8)-Tetrahydrocannabinol (26), 3-(1',1'-dimethylbutyl)- (12), 3-(1',1'-dimethylpentyl)- (13), 3-(1',1'-dimethylhexyl)- (14) and 3-(1',1'-dimethylheptyl)-Δ(8)-tetrahydrocannabinol (15) have been converted into the corresponding 1-bromo-1-deoxy-Δ(8)-tetrahydrocannabinols (25, 8-11). This was accomplished using a protocol developed in our laboratory in which the trifluoromethanesulfonate of a phenol undergoes palladium mediated coupling with pinacolborane. Reaction of this dioxaborolane with aqueous-methanolic copper(II) bromide provides the aryl bromide. The affinities of these bromo cannabinoids for the cannabinoid CB(1) and CB(2) receptors were determined. All of these compounds showed selectivity for the CB(2) receptor and one of them, 1-bromo-1-deoxy-3-(1',1'-dimethylhexyl)-Δ(8)-tetrahydrocannabinol (10), exhibits 52-fold selectivity for this receptor with good (28nM) affinity.

摘要

Δ(8)-四氢大麻醇(26)、3-(1',1'-二甲基丁基)- (12)、3-(1',1'-二甲基戊基)- (13)、3-(1',1'-二甲基己基)- (14)和 3-(1',1'-二甲基庚基)-Δ(8)-四氢大麻醇(15)已转化为相应的 1-溴-1-脱氧-Δ(8)-四氢大麻醇(25、8-11)。这是使用我们实验室开发的方案完成的,其中酚的三氟甲磺酸酯通过钯介导与频哪醇硼烷偶联。该二氧硼烷与水-甲醇铜(II)溴化物反应得到芳基溴化物。这些溴代大麻素对大麻素 CB(1)和 CB(2)受体的亲和力进行了测定。所有这些化合物都显示出对 CB(2)受体的选择性,其中一种化合物 1-溴-1-脱氧-3-(1',1'-二甲基己基)-Δ(8)-四氢大麻醇(10)对该受体具有 52 倍的选择性,亲和力良好(28nM)。

相似文献

1
1-Bromo-3-(1',1'-dimethylalkyl)-1-deoxy-Δ(8)-tetrahydrocannabinols: New selective ligands for the cannabinoid CB(2) receptor.1-溴-3-(1',1'-二甲基烷基)-1-去氧-Δ(8)-四氢大麻醇:大麻素 CB(2)受体的新型选择性配体。
Bioorg Med Chem. 2010 Nov 15;18(22):7809-15. doi: 10.1016/j.bmc.2010.09.061. Epub 2010 Sep 29.
2
1-Methoxy-, 1-deoxy-11-hydroxy- and 11-hydroxy-1-methoxy-Delta(8)-tetrahydrocannabinols: new selective ligands for the CB2 receptor.1-甲氧基、1-脱氧-11-羟基和11-羟基-1-甲氧基-Δ(8)-四氢大麻酚:CB2受体的新型选择性配体。
Bioorg Med Chem. 2002 Dec;10(12):4119-29. doi: 10.1016/s0968-0896(02)00331-0.
3
One-pot heterogeneous synthesis of Δ(3)-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB(1) and CB(2) receptors.一锅法多相合成对CB(1)和CB(2)受体具有不同结合能力的Δ(3)-四氢大麻酚类似物和呫吨类化合物。
Eur J Med Chem. 2014 Oct 6;85:77-86. doi: 10.1016/j.ejmech.2014.07.062. Epub 2014 Jul 19.
4
3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor.3-(1',1'-二甲基丁基)-1-脱氧-δ8-四氢大麻酚及相关化合物:CB2受体选择性配体的合成
Bioorg Med Chem. 1999 Dec;7(12):2905-14. doi: 10.1016/s0968-0896(99)00219-9.
5
Similarities and differences upon binding of naturally occurring Δ-tetrahydrocannabinol-derivatives to cannabinoid CB and CB receptors.天然产生的Δ-四氢大麻酚衍生物与大麻素 CB 和 CB 受体结合的相似性和差异性。
Pharmacol Res. 2021 Dec;174:105970. doi: 10.1016/j.phrs.2021.105970. Epub 2021 Nov 7.
6
CB2 receptor ligands.CB2受体配体
Mini Rev Med Chem. 2005 Jul;5(7):641-9. doi: 10.2174/1389557054368844.
7
Adamantyl cannabinoids: a novel class of cannabinergic ligands.金刚烷基大麻素:一类新型大麻素能配体。
J Med Chem. 2005 Jul 14;48(14):4576-85. doi: 10.1021/jm058175c.
8
Structural analogs of pyrazole and sulfonamide cannabinoids: effects on acute food intake in mice.吡唑和磺胺类大麻素的结构类似物:对小鼠急性食物摄入量的影响。
Eur J Pharmacol. 2012 Nov 15;695(1-3):62-70. doi: 10.1016/j.ejphar.2012.08.019. Epub 2012 Sep 6.
9
Novel 1',1'-chain substituted Delta(8)-tetrahydrocannabinols.新型1',1'-链取代的δ(8)-四氢大麻酚。
Bioorg Med Chem Lett. 2002 Dec 16;12(24):3583-6. doi: 10.1016/s0960-894x(02)00785-0.
10
Structural modifications of the cannabinoid side chain towards C3-aryl and 1',1'-cycloalkyl-1'-cyano cannabinoids.大麻素侧链向C3-芳基和1',1'-环烷基-1'-氰基大麻素的结构修饰。
Bioorg Med Chem Lett. 2006 Mar 15;16(6):1616-20. doi: 10.1016/j.bmcl.2005.12.026. Epub 2006 Jan 4.

引用本文的文献

1
Cannabinoids in Integumentary Wound Care: A Systematic Review of Emerging Preclinical and Clinical Evidence.大麻素在皮肤伤口护理中的应用:新兴临床前和临床证据的系统评价
Pharmaceutics. 2024 Aug 17;16(8):1081. doi: 10.3390/pharmaceutics16081081.
2
Syntheses of Cannabinoid Metabolites: Ajulemic Acid and HU-210.大麻素代谢物的合成:阿居列米酸和HU - 210。
Molecules. 2024 Jan 21;29(2):526. doi: 10.3390/molecules29020526.
3
Cannabis alters epigenetic integrity and endocannabinoid signalling in the human follicular niche.大麻改变了人类滤泡龛中的表观遗传完整性和内源性大麻素信号。
Hum Reprod. 2021 Jun 18;36(7):1922-1931. doi: 10.1093/humrep/deab104.
4
CB2 receptor-selective agonists as candidates for targeting infection, inflammation, and immunity in SARS-CoV-2 infections.CB2受体选择性激动剂作为治疗SARS-CoV-2感染中感染、炎症和免疫靶点的候选药物。
Drug Dev Res. 2021 Feb;82(1):7-11. doi: 10.1002/ddr.21752. Epub 2020 Nov 15.
5
Synthesis of Functionalized Cannabilactones.功能化 Cannabilactones 的合成。
Molecules. 2020 Feb 6;25(3):684. doi: 10.3390/molecules25030684.
6
Paternal activation of CB cannabinoid receptor impairs placental and embryonic growth via an epigenetic mechanism.父系激活 CB 大麻素受体通过表观遗传机制损害胎盘和胚胎生长。
Sci Rep. 2019 Nov 19;9(1):17034. doi: 10.1038/s41598-019-53579-3.
7
Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation.大麻素受体 2:在免疫调节和神经炎症中的潜在作用。
J Neuroimmune Pharmacol. 2013 Jun;8(3):608-20. doi: 10.1007/s11481-013-9445-9. Epub 2013 Mar 8.
8
Latest advances in novel cannabinoid CB(2) ligands for drug abuse and their therapeutic potential.新型大麻素 CB(2)配体在药物滥用及治疗潜力方面的最新进展。
Future Med Chem. 2012 Feb;4(2):187-204. doi: 10.4155/fmc.11.179.

本文引用的文献

1
Discovery of 2-[(2,4-dichlorophenyl)amino]-N-[(tetrahydro- 2H-pyran-4-yl)methyl]-4-(trifluoromethyl)- 5-pyrimidinecarboxamide, a selective CB2 receptor agonist for the treatment of inflammatory pain.发现2-[(2,4-二氯苯基)氨基]-N-[(四氢-2H-吡喃-4-基)甲基]-4-(三氟甲基)-5-嘧啶甲酰胺,一种用于治疗炎性疼痛的选择性CB2受体激动剂。
J Med Chem. 2007 May 31;50(11):2597-600. doi: 10.1021/jm061195+. Epub 2007 May 4.
2
The endocannabinoid system as an emerging target of pharmacotherapy.内源性大麻素系统作为药物治疗的一个新兴靶点。
Pharmacol Rev. 2006 Sep;58(3):389-462. doi: 10.1124/pr.58.3.2.
3
Cannabinoid receptors as therapeutic targets.大麻素受体作为治疗靶点。
Annu Rev Pharmacol Toxicol. 2006;46:101-22. doi: 10.1146/annurev.pharmtox.46.120604.141254.
4
Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists.1-烷基-3-(1-萘甲酰基)吲哚在大麻素CB(1)和CB(2)受体上的构效关系:萘甲酰基取代基的空间和电子效应。新型高选择性CB(2)受体激动剂。
Bioorg Med Chem. 2005 Jan 3;13(1):89-112. doi: 10.1016/j.bmc.2004.09.050.
5
Cannabinoids: potential anticancer agents.大麻素:潜在的抗癌药物。
Nat Rev Cancer. 2003 Oct;3(10):745-55. doi: 10.1038/nrc1188.
6
Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS.AM1241对CB2大麻素受体的激活可抑制实验性神经病理性疼痛:中枢神经系统中不存在的受体对疼痛的抑制作用。
Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10529-33. doi: 10.1073/pnas.1834309100. Epub 2003 Aug 13.
7
Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models.在神经性而非炎性慢性疼痛模型的大鼠脊髓中诱导CB2受体表达。
Eur J Neurosci. 2003 Jun;17(12):2750-4. doi: 10.1046/j.1460-9568.2003.02704.x.
8
A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain.一种大麻素激动剂在癌症和炎性肌肉疼痛动物模型中对深部组织痛觉过敏有不同程度的减轻作用。
Pain. 2003 May;103(1-2):175-86. doi: 10.1016/s0304-3959(02)00450-5.
9
Structure-activity relationships for 1',1'-dimethylalkyl-Delta8-tetrahydrocannabinols.1',1'-二甲基烷基-Δ8-四氢大麻酚的构效关系
Bioorg Med Chem. 2003 Apr 3;11(7):1397-410. doi: 10.1016/s0968-0896(02)00649-1.
10
Inhibition of pain responses by activation of CB(2) cannabinoid receptors.通过激活CB(2) 大麻素受体抑制疼痛反应。
Chem Phys Lipids. 2002 Dec 31;121(1-2):191-200. doi: 10.1016/s0009-3084(02)00155-x.